en.unionpedia.org

BAY 59-3074, the Glossary

Index BAY 59-3074

BAY 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by Bayer AG.[1]

Table of Contents

  1. 7 relations: Analgesic, Bayer, Cannabinoid receptor, Cannabinoid receptor 1, Cannabinoid receptor 2, Dissociation constant, Partial agonist.

  2. 2-Hydroxybenzonitrile ethers
  3. Diphenyl ethers
  4. Phenyl sulfonate ethers
  5. Resorcinol ethers

Analgesic

An analgesic drug, also called simply an analgesic, antalgic, pain reliever, or painkiller, is any member of the group of drugs used for pain management.

See BAY 59-3074 and Analgesic

Bayer

Bayer AG (English:, commonly pronounced) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world.

See BAY 59-3074 and Bayer

Cannabinoid receptor

Cannabinoid receptors, located throughout the body, are part of the endocannabinoid system of vertebrates a class of cell membrane receptors in the G protein-coupled receptor superfamily.

See BAY 59-3074 and Cannabinoid receptor

Cannabinoid receptor 1

Cannabinoid receptor 1 (CB1), is a G protein-coupled cannabinoid receptor that in humans is encoded by the CNR1 gene.

See BAY 59-3074 and Cannabinoid receptor 1

Cannabinoid receptor 2

The cannabinoid receptor 2 (CB2), is a G protein-coupled receptor from the cannabinoid receptor family that in humans is encoded by the CNR2 gene.

See BAY 59-3074 and Cannabinoid receptor 2

Dissociation constant

In chemistry, biochemistry, and pharmacology, a dissociation constant (KD) is a specific type of equilibrium constant that measures the propensity of a larger object to separate (dissociate) reversibly into smaller components, as when a complex falls apart into its component molecules, or when a salt splits up into its component ions.

See BAY 59-3074 and Dissociation constant

Partial agonist

In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist.

See BAY 59-3074 and Partial agonist

See also

2-Hydroxybenzonitrile ethers

Diphenyl ethers

Phenyl sulfonate ethers

Resorcinol ethers

References

[1] https://en.wikipedia.org/wiki/BAY_59-3074

Also known as C18H13F6NO4S.